NORTHWOOD, OHIO, USA – March 26, 2013 – NAMSA, the world’s leading medical research organization, continues its steady growth with the expansion of its microbiology laboratory in Irvine, California. The newly expanded and state-of-the-art laboratory space will utilize the latest technology for microbiology and sterility assurance testing and will open in spring 2013.

NAMSA is delighted to announce the addition of remote training seminars.  NAMSA Remote Training Seminars provide high level content and industry expert analysis on prevailing global topics in the medical device industry.  The one hour phone conferences offer insight on regulatory and clinical issues and concerns medical device manufacturer’s encounter in their development process.
We will be offering four seminars from April to July.  

NAMSA, the world's leading medical research organization, would like to invite you to join us at BPMDS 2013 for a rare gathering..

NORTHWOOD, OHIO – Jan. 8, 2013 – NAMSA, the world’s leading medical device research organization, is sponsoring a comprehensive symposium based on the definitive new book, “Biocompatibility and Performance of Medical Devices,” assembled by ANSM expert Dr. Jean-Pierre Boutrand, in London, England, February 12-14. This one-of-a-kind event offers attendees crucial insights on medical device testing.

NORTHWOOD, OHIO, USA – Oct. 15, 2012 – NAMSA, the world’s leading medical device research organization, continues its steady growth with an expansion of its state-of-the-art laboratories in Lyon, France.

Increased demand for NAMSA’s biocompatibility and histopathology services has led the company to invest in building an additional 12,000 square feet for its facility, which increases its capacity in Lyon by roughly 30 percent.

NAMSA, the world’s leading medical device research organization, has acquired The Integra Group, a preclinical and clinical research organization located near Minneapolis. The medical device research, regulatory approval and commercialization process is continuously taking longer and costing more.  Having breadth and depth in consulting, non-clinical and clinical services with experts in cardiovascular, orthopedic, ocular, neurologic, gastroenterologic, urologic, combination product and related medical devices can help manufacturers accelerate these development efforts.

NORTHWOOD, OHIO – June 1, 2012 – NAMSA, a world leading contract research organization for medical devices, announced that its French business unit, Biomatech, will now conduct business under the NAMSA brand name.

February 21, 2012

For several years, NAMSA has offered metal analysis by Inductively Coupled Plasma Optical Emission Spectrometry (ICP-OES). As NAMSA continues to make vast improvements in our facility and instrumentation, we are proud to announce that NAMSA will now also be offering Inductively Coupled Plasma Mass Spectrometry (ICP-MS).